DOI QR코드

DOI QR Code

Association of XRCC3 Thr241Met Polymorphisms and Gliomas Risk: Evidence from a Meta-analysis

  • Liang, Hong-Jie (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Yan, Yu-Lan (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Liu, Zhi-Ming (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Chen, Xu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Peng, Qi-Liu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Wang, Jian (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Mo, Cui-Ju (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Sui, Jing-Zhe (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Wu, Jun-Rong (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Zhai, Li-Min (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Yang, Shi (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Li, Tai-Jie (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Li, Ruo-Lin (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Li, Shan (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) ;
  • Qin, Xue (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University)
  • Published : 2013.07.30

Abstract

The relationship between the X-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism and gliomas remains inclusive or controversial. For better understanding of the effect of XRCC3 Thr241Met polymorphism on glioma risk, a meta-analysis was performed. All eligible studies were identified through a search of PubMed, Elsevier Science Direct, Excerpta Medica Database (Embase) and Chinese Biomedical Literature Database (CBM) before May 2013. The association between the XRCC3 Thr241Met polymorphism and gliomas risk was conducted by odds ratios (ORs) and 95% confidence intervals (95% CIs). A total of nine case-control studies including 3,533 cases and 4,696 controls were eventually collected. Overall, we found that XRCC3 Thr241Met polymorphism was significantly associated with the risk of gliomas (T vs. C: OR=1.10, 95%CI=1.01-1.20, P=0.034; TT vs. CC: OR=1.30, 95%CI=1.03-1.65, P=0.027; TT vs. TC/CC: OR=1.29, 95%CI=1.01-1.64, P=0.039). In the subgroup analysis based on ethnicity, the significant association was found in Asian under four models (T vs. C: OR=1.17, 95%CI=1.07-1.28, P=0.00; TT vs. CC: OR=1.79, 95%CI=1.36-2.36, P=0.00; TT vs. TC/CC: OR=1.75, 95%CI=1.32-2.32, P=0.00; TT/TC vs. CC: OR=1.11,95% CI=1.02-1.20). This meta-analysis suggested that the XRCC3 Thr241Met polymorphism is a risk factor for gliomas, especially for Asians. Considering the limited sample size and ethnicities included in the meta-analysis, further large scale and well-designed studies are needed to confirm our results.

Keywords

XRCC3;gliomas;polymorphism;meta-analysis

References

  1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  2. Custodio AC, Almeida, LO, Pinto, GR, et al (2012). Variation in DNA repair gene XRCC3 affects susceptibility to astrocytomas and glioblastomas. Genet Mol Res, 11, 332-9. https://doi.org/10.4238/2012.February.10.4
  3. DerSimonian, R. and Laird, N., (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  4. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  5. Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
  6. He XF, Wei W, Li JL, et al (2013). Association between the XRCC3 T241M polymorphism and risk of cancer: Evidence from 157 case-control studies. Gene, 523, 10-9. https://doi.org/10.1016/j.gene.2013.03.071
  7. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
  8. Kiuru A, Lindholm C, Heinavaara S, et al (2008). XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol, 88, 135-42. https://doi.org/10.1007/s11060-008-9556-y
  9. Kyritsis AP, Bondy ML, Rao JS, et al (2010) Inherited predisposition to glioma. Neuro Oncol, 12, 104-13. https://doi.org/10.1093/neuonc/nop011
  10. Liu HB, Peng, YP, Dou CW, et al (2012). Comprehensive study on associations between nine SNPs and glioma risk. Asian Pac J Cancer Prev, 13, 4905-8. https://doi.org/10.7314/APJCP.2012.13.10.4905
  11. Liu Y, Scheurer ME, El-Zein R, et al (2009). Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev, 18, 204-14. https://doi.org/10.1158/1055-9965.EPI-08-0632
  12. Luo, KQ, Mu, SQ, Wu, ZX, et al (2013). Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev, 14, 449-52. https://doi.org/10.7314/APJCP.2013.14.1.449
  13. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  14. Melin B (2011). Genetic causes of glioma: new leads in the labyrinth. Curr Opin Oncol, 23, 643-7. https://doi.org/10.1097/CCO.0b013e32834a6f61
  15. Pan WR, Li G, Guan JH (2013). Polymorphisms in DNA repair genes and susceptibility to glioma in a Chinese population. Int J Mol Sci, 14, 3314-24. https://doi.org/10.3390/ijms14023314
  16. Prasad G, Haas-Kogan DA (2009). Radiation-induced gliomas. Expert Rev Neurother, 9, 1511-7. https://doi.org/10.1586/ern.09.98
  17. Rajaraman P, Hutchinson A, Wichner S, et al (2010). DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol, 12, 37-48. https://doi.org/10.1093/neuonc/nop012
  18. Tebbs, RS, Zhao, Y, Tucker, JD, et al (1995). Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci USA, 92, 6354-8. https://doi.org/10.1073/pnas.92.14.6354
  19. Wang LE, Bondy ML, Shen H, et al (2004). Polymorphisms of DNA repair genes and risk of glioma. Cancer Res, 64, 5560-3. https://doi.org/10.1158/0008-5472.CAN-03-2181
  20. Zhou K, Liu Y, Zhang H, et al (2007). Association between XRCC3 Thr 241 Met polymorphism and genetic susceptibility to glioma in Chinese Han population living in Shanghai and surrounding province in east China. Acad J Sec Mil Med Univ, 28, 364-8. article in Chinese.
  21. Zhou K, Liu Y, Zhang H, et al (2009). XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int J Cancer, 124, 2948-53. https://doi.org/10.1002/ijc.24307

Cited by

  1. Association Between the XRCC3 Thr241Met Polymorphism and Cervical Cancer Risk: a Meta-analysis vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6703
  2. Associations between the rs6010620 Polymorphism in RTEL1 and Risk of Glioma: a Meta-analysis of 20,711 Participants vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7163
  3. Environmental Exposure to Lead (Pb) and Variations in Its Susceptibility vol.32, pp.2, 2014, https://doi.org/10.1080/10590501.2014.907461
  4. Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis vol.10, pp.6, 2015, https://doi.org/10.1371/journal.pone.0130388
  5. The RTEL1 rs6010620 Polymorphism and Glioma Risk: a Meta-analysis Based on 12 Case-control Studies vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10175
  6. Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met Gene Polymorphisms with Increased Risk of Head and Neck Cancer vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10457
  7. Association of the CCDC26 rs4295627 polymorphism with the risk of glioma: Evidence from 7,290 cases and 11,630 controls vol.4, pp.5, 2016, https://doi.org/10.3892/mco.2016.813
  8. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk vol.53, pp.7, 2016, https://doi.org/10.1007/s12035-015-9346-4
  9. Clinical and molecular aspects of lead toxicity: An update vol.54, pp.7-8, 2017, https://doi.org/10.1080/10408363.2017.1408562
  10. NOTCH3 Gene Polymorphism is Associated With the Prognosis of Gliomas in Chinese Patients vol.94, pp.9, 2015, https://doi.org/10.1097/MD.0000000000000482
  11. with Glioma in a Chinese Population vol.19, pp.1, 2015, https://doi.org/10.1089/gtmb.2014.0228